Marcos Steinberg

Marcos Steinberg currently serves as the Director of Immunology at Vividion Therapeutics, Inc., a position held since June 2023. Prior experience includes serving as the Director of Biology at Gossamer Bio, where responsibility encompassed leading an immuno-oncology program and supervising translational biology activities for a BTK inhibitor program. Marcos has held prominent roles such as Principal Scientist at Bristol-Myers Squibb, Principal Scientist at Celgene, and Senior Scientist at Receptos, focusing extensively on inflammatory disorders and early-stage research for small molecule therapeutics. Earlier experience includes research positions at Tanabe Research Laboratories and the La Jolla Institute for Allergy and Immunology, with foundational training gained during postdoctoral fellowships and collaborative research projects. Academic credentials include a Ph.D. in Immunology and a Master of Science, both obtained from the Institut de Genetique Moleculaire de Montpellier, alongside a Bachelor of Science in Biology from the University of Buenos Aires.